Adam Rogers
Direktor/Vorstandsmitglied bei NERVGEN PHARMA CORP.
Vermögen: 15 000 $ am 30.04.2024
Profil
Dr. Adam Rogers, MD, is a Chief Executive Officer at Hemera Biosciences, Inc. He is on the Board of Directors at NervGen Pharma Corp.
and One Family, Inc. Dr. Rogers was previously employed as a Member by Emory University School of Medicine.
He received his undergraduate degree from Emory University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NERVGEN PHARMA CORP.
0,02% | 23.05.2023 | 10 000 ( 0,02% ) | 15 000 $ | 30.04.2024 |
Aktive Positionen von Adam Rogers
| Unternehmen | Position | Beginn |
|---|---|---|
| NERVGEN PHARMA CORP. | Direktor/Vorstandsmitglied | 14.07.2022 |
Hemera Biosciences, Inc.
 Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Vorstandsvorsitzender | 01.01.2017 |
| One Family, Inc. | Direktor/Vorstandsmitglied | 01.01.2007 |
Ehemalige bekannte Positionen von Adam Rogers
| Unternehmen | Position | Ende |
|---|---|---|
| Emory University School of Medicine | Corporate Officer/Principal | 02.01.1991 |
Ausbildung von Adam Rogers
| Emory University School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hemera Biosciences, Inc.
Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Health Technology |
| One Family, Inc. |
